Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,748 public trials 646 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Seasonal Allergic Rhinitis In Pediatric Subjects

NCT00107757

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Costa Mesa, California, United States
  • GSK Investigational Site Cudahy, California, United States
View all 65 locations
View Trial Details
Completed

A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.

NCT01499446

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
  • GSK Investigational Site Pleven, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
View all 64 locations
View Trial Details
Completed

Advair Pediatric Once-Daily

NCT00920959

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Ozark, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 149 locations
View Trial Details
Completed

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

NCT00116883

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Hot Springs, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View Trial Details

Related conditions